On December 11, 2022, Li Yan led students of the 2022 MBA (medical management direction) of Shenzhen University visited Shutang Information Technology (Shenzhen) Co., Ltd., and carried out an immersive experience of English teaching in high-tech enterprises, bringing unique learning experience to students.
Shutang Information Technology (Shenzhen) Co., Ltd. was a scientific and innovative company focusing on non-invasive continuous blood glucose monitoring technology. Manager Chen Minzhuang, head of research and development, introduced the mind course of the start-up company in English, and showed the three generations of wearable intelligent non-invasive detector developed by the company, and introduced the company's organizational structure, research and development team, cultural philosophy and development advantages in detail.
The students made an active speech on the spot and asked questions on the technical characteristics, market planning, development prospects, data security, the survival and development of start-ups, and the management philosophy and culture of Hong Kong-funded enterprises.
Li Liang, one of the students, experienced the non-invasive blood glucose monitoring function of the company's third generation wearable smart watch on the spot, and talked about his understanding of the medical big health, his dream and how to grasp the opportunity of the big health era. On behalf of all the students, Zhang Chaolong, the representative of the students, summed up today's learning achievements in fluent English, and expressed his sincere gratitude to Mr. Chen for this valuable opportunity.
The learning activity in the enterprise was designed by the teachers according to the course process. As a Hong Kong-funded high-tech start-up company, Shutang Information Technology (Shenzhen) Co., Ltd. shared its entrepreneurial experience, core products, organizational structure, and management philosophy and culture. The vivid immersion teaching in English not only greatly improves the students' English ability, opens up their international vision, but also fills us with expectations for the future of the integration of science and technology development and medical treatment in the big health industry.
